1. Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition
   Daniel K. Glatzel et al, 2018, Journal of Lipid Research CrossRef
2. The intersection between Wnt signaling pathway and cancer metabolism
   Wenzhu Liu, 2022, 7TH INTERNATIONAL CONFERENCE ON MATHEMATICS: PURE, APPLIED AND COMPUTATION: Mathematics of Quantum Computing CrossRef
3. Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
   Jialei Weng et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
4. Aging AdipoR2‐deficient mice are hyperactive with enlarged brains excessively rich in saturated fatty acids
   Mario Ruiz et al, 2024, The FASEB Journal CrossRef
5. The differential role of resistin on invasive liver cancer cells
   Candace Miethe et al, 2023, Hormone Molecular Biology and Clinical Investigation CrossRef
6. A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
   Li Yang et al, 2016, Oncotarget CrossRef
7. Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison
   Serena Castelli et al, 2021, Cancers CrossRef
8. Autophagy activation and SREBP‐1 induction contribute to fatty acid metabolic reprogramming by leptin in breast cancer cells
   Duc‐Vinh Pham et al, 2021, Molecular Oncology CrossRef
9. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
   Nicola Antonio di Meo et al, 2023, Expert Review of Molecular Diagnostics CrossRef
10. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs
    Maria Malvina Tsamouri et al, 2022, Metabolites CrossRef
11. [Retracted] Nanoemulsion and Encapsulation Strategy of Hydrophobic Oregano Essential Oil Increased Human Prostate Cancer Cell Death via Apoptosis by Attenuating Lipid Metabolism
    Haribalan Perumalsamy et al, 2022, Bioinorganic Chemistry and Applications CrossRef
12. The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells
    Javier A. Menendez et al, 2016, Oncoscience CrossRef
13. Structural characterization of human O-phosphoethanolamine phospho-lyase
    Chiara Vettraino et al, 2020, Acta Crystallographica Section F Structural Biology Communications CrossRef
14. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
    Davide Gnocchi et al, 2023, International Journal of Molecular Sciences CrossRef
15. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis
    Kyung Ha Lee et al, 2017, Molecular Medicine Reports CrossRef
16. Silencing of ECHDC1 inhibits growth of gemcitabine‑resistant bladder cancer cells
    Seiji Asai et al, 2017, Oncology Letters CrossRef
17. Aberrant high expression level of MORC2 is a common character in multiple cancers
    Qian-shan Ding et al, 2018, Human Pathology CrossRef
18. A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic mice
    Pan Diao et al, 2020, The Journal of Nutritional Biochemistry CrossRef
19. Pleiotrophin, a target of miR‐384, promotes proliferation, metastasis and lipogenesis in HBV‐related hepatocellular carcinoma
    Pei‐song Bai et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
20. AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis
    Qianshan Ding et al, 2016, Journal of Clinical Pathology CrossRef
21. Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer
    Ting Li et al, 2023, Environmental Toxicology CrossRef
22. Tumour growth inhibitory effect of Ibervillea sonorae phytopreparations in cervical cancer xenografts
    Max Vidal-Gutiérrez et al, 2024, Natural Product Research CrossRef
23. Paradigm shift: the primary function of the “Adiponectin Receptors” is to regulate cell membrane composition
    Marc Pilon, 2021, Lipids in Health and Disease CrossRef
24. Diagnostic Challenges of Kidney Cancer: A Systematic Review of the Role of Positron Emission Tomography-Computerized Tomography
    Ofer N. Gofrit et al, 2016, Journal of Urology CrossRef
25. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor
    Satoru Nishizawa et al, 2017, European Journal of Pharmacology CrossRef
26. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer
    Jianqing Qiu et al, 2024, Cancer Biology & Therapy CrossRef
27. TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers
    Katharina Leithner et al, 2016, PLOS ONE CrossRef
28. Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation
    Girolamo Ranieri et al, 2017, International Journal of Molecular Sciences CrossRef
29. Reticular Whitish Gray Lesions of the Oral Mucosa with No Habit History: A Critical Appraisal
    Archana Gupta et al, 2018, World Journal of Dentistry CrossRef
30. Leveraging a gain-of-function allele of Caenorhabditis elegans paqr-1 to elucidate membrane homeostasis by PAQR proteins
    Kiran Busayavalasa et al, 2020, PLOS Genetics CrossRef
31. The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN
    Tao Jiang et al, 2024, Molecular Cancer CrossRef
32. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes
    Li-Chiung Lin et al, 2017, Cancer Letters CrossRef
33. Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer
    Matthew Alberto et al, 2023, Cancers CrossRef
34. Metabolic adaptations in prostate cancer
    Mikel Pujana-Vaquerizo et al, 2024, British Journal of Cancer CrossRef
35. Antitumor effects of curcumin: A lipid perspective
    Mehri Bemani Naeini et al, 2019, Journal of Cellular Physiology CrossRef
36. Biguanides drugs: Past success stories and promising future for drug discovery
    Oleksandr Grytsai et al, 2021, European Journal of Medicinal Chemistry CrossRef
37. Association of saturated fatty acids with cancer risk: a systematic review and meta-analysis
    Jin Mei et al, 2024, Lipids in Health and Disease CrossRef
38. Metabolic protein kinase signalling in neuroblastoma
    William J. Smiles et al, 2023, Molecular Metabolism CrossRef
39. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
    Shoeb Ikhlas et al, 2017, Life Sciences CrossRef
40. Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis
    Rajni Kumari et al, 2019, Nature Communications CrossRef
41. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
    Dimitri Vanauberg et al, 2023, Oncogenesis CrossRef
42. Stearoyl-CoA Desaturase-1 Enzyme Inhibition by Grape Skin Extracts Affects Membrane Fluidity in Human Colon Cancer Cell Lines
    Valeria Tutino et al, 2020, Nutrients CrossRef
43. A review on the role of fatty acids in colorectal cancer progression
    Malvina Hoxha et al, 2022, Frontiers in Pharmacology CrossRef
44. Metabolic response to radiation therapy in cancer
    Graham H. Read et al, 2022, Molecular Carcinogenesis CrossRef
45. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells
    Candace Miethe et al, 2019, Hormone Molecular Biology and Clinical Investigation CrossRef
46. Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
    Mi-Rae Shin et al, 2020, Canadian Journal of Gastroenterology and Hepatology CrossRef
47. Prostate Cancer: Advances in Genetic Testing and Clinical Implications
    Ahmad S. Abdelrazek et al, 2023, Uro CrossRef
48. Celecoxib alleviates AKT/c‐Met‐triggered rapid hepatocarcinogenesis by suppressing a novel COX‐2/AKT/FASN cascade
    Zhenpeng Qiu et al, 2019, Molecular Carcinogenesis CrossRef
49. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
    Yunxin Liu et al, 2020, Biochemical Pharmacology CrossRef
50. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway
    Lin Wang et al, 2018, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
51. Nickel inhibits mitochondrial fatty acid oxidation
    Radha Uppala et al, 2015, Biochemical and Biophysical Research Communications CrossRef
52. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
    Shanmugam Murugaiha Jeyakumar et al, 2022, World Journal of Hepatology CrossRef
53. AKT and ERK dual inhibitors: The way forward?
    Zhe Cao et al, 2019, Cancer Letters CrossRef
54. Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates
    Curtis C. Hughey et al, 2018, Journal of Biological Chemistry CrossRef
55. Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC
    Hiba S Al-Amodi et al, 2024, Cureus CrossRef
56. Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells
    Jessica E. C. Jones et al, 2017, PLOS ONE CrossRef
57. O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes
    Steffi F. Baldini et al, 2016, Frontiers in Oncology CrossRef
58. Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells
    Jia-Bao Yan et al, 2020, Molecular Therapy - Oncolytics CrossRef
59. Fatty acid synthesis and prostate cancer
    Tomas Koltai et al, 2021, Prostate Cancer Metabolism CrossRef
60. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
    Geraldine Harriman et al, 2016, Proceedings of the National Academy of Sciences CrossRef
61. Role of Lipogenesis Rewiring in Hepatocellular Carcinoma
    Yi Zhou et al, 2022, Seminars in Liver Disease CrossRef
62. Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
    Yu-Ting Tsai et al, 2022, Journal of Biomedical Science CrossRef
63. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
    Yi Zhang et al, 2023, Biomolecules CrossRef
64. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis
    Yi Wang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
65. Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition
    Akito Ono et al, 2017, PLOS ONE CrossRef
66. Lipid metabolism reprogramming in renal cell carcinoma
    Gioia Heravi et al, 2022, Cancer and Metastasis Reviews CrossRef
67. A review on anti-cancer properties of Quercetin in breast cancer
    Maryam Ezzati et al, 2020, Life Sciences CrossRef
68. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
    Marko Hojnik et al, 2021, Cancers CrossRef
69. Lipid Metabolism—An Aberrant Shift in Cancer: A Narrative Review
    Samudrala V Sowmya et al, 2018, World Journal of Dentistry CrossRef
70. miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell
    Ao Wang et al, 2021, Anti-Cancer Drugs CrossRef
71. Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling
    Hye-Youn Kim et al, 2017, Scientific Reports CrossRef
72. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters
    Josiane Elia et al, 2019, Lipids in Health and Disease CrossRef
73. GCN5 acetyltransferase in cellular energetic and metabolic processes
    Beste Mutlu et al, 2021, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
74. Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer
    Mohamed Amine Lounis et al, 2020, Cancers CrossRef
75. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
    Nuzhat Ahmed et al, 2016, Scientific Reports CrossRef
76. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
    Marko Hojnik et al, 2022, Cancers CrossRef
77. Altered metabolism in cancer: insights into energy pathways and therapeutic targets
    Muhammad Tufail et al, 2024, Molecular Cancer CrossRef
78. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
    R. Ariel Igal, 2016, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
79. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma
    Jianfeng Wang et al, 2016, PLOS ONE CrossRef
80. Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism
    Tatsuo Kanda et al, 2017, Oncology Letters CrossRef
81. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
    Johanna K. DiStefano et al, 2019, Cancers CrossRef
82. Targeting dysregulated lipid metabolism in the tumor microenvironment
    Do-Hee Kim et al, 2023, Archives of Pharmacal Research CrossRef
83. Application of 1H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma
    Rosina Sánchez Solé et al, 2024, Veterinary and Comparative Oncology CrossRef
84. Stearoyl-CoA desaturase 1 inhibitor supplemented with gemcitabine treatment reduces the viability and fatty acid content of pancreatic cancer cells in vitro
    Amon B. Hackney et al, 2021, Journal of Pancreatology CrossRef
85. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
    Serena De Matteis et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
86. Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis
    Praveenkumar Basavaraj et al, 2022, Life CrossRef
87. LncRNA SNHG16 Induces the SREBP2 to Promote Lipogenesis and Enhance the Progression of Pancreatic Cancer
    Yi Yu et al, 2019, Future Oncology CrossRef
88. Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
    Advait Shetty et al, 2020, ACS Omega CrossRef
89. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation
    Arthur Cassio de Lima Luna et al, 2021, Molecular and Cellular Biochemistry CrossRef